Milk thistle extract
CAS 84604-20-6
Milk thistle extract (CAS 84604-20-6) is a pharmaceutical compound with 0 bioactivity targets and 582 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Milk thistle extract is linked to DTXSID8031657 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Milk thistle extract used for in pharmaceutical contexts?
Milk thistle extract (CAS 84604-20-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Milk thistle extract?
Milk thistle extract has 582 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Acne. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Milk thistle extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Nannochloropsis Oculata Extract with EU status "permitted".
What clinical phase is Milk thistle extract in?
No phase 1-4 clinical development badge is rendered for Milk thistle extract because the matched compound identifier rows do not contain a max-phase value.